Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:ALSN
NYSE:ALSNMachinery

How Allison’s New Two-Unit Structure and Off-Highway Leadership Shift At Allison Transmission Holdings (ALSN) Has Changed Its Investment Story

Allison Transmission Holdings has reorganized into two business units, Allison Transmission and Allison Off-Highway Drive & Motion Systems, with Fred Bohley and newly appointed executive Craig Price leading the units and reporting to CEO David Graziosi. The hiring of Price from Dana’s Off-Highway business, alongside his long tenure in purchasing and supplier development, signals a push to tightly manage costs and extract efficiencies from the recently acquired operations. Next, we’ll examine...
ASX:ASB
ASX:ASBAerospace & Defense

Austal (ASX:ASB) Valuation Review As All Time High Follows Major Defence Contract Wins

Austal (ASX:ASB) has hit an all time high after securing a Strategic Shipbuilding Agreement with the Australian Government worth an initial A$1b to A$1.3b and expanding its U.S. shipyard operations. See our latest analysis for Austal. That agreement and the U.S. yard expansion sit on top of strong recent momentum, with a 30 day share price return of 33.74% and a 1 year total shareholder return of 178.10% signaling that investors are aggressively repricing Austal’s defence exposure. If...
NYSE:SHO
NYSE:SHOHotel and Resort REITs

Assessing Sunstone Hotel Investors (SHO) Valuation After Baird Downgrade And Steady Dividend Yield

Baird’s downgrade of Sunstone Hotel Investors (SHO) from Outperform to Neutral puts fresh attention on the REIT’s positioning versus peers, particularly given its consistent dividend history and current 3.82% yield. See our latest analysis for Sunstone Hotel Investors. The Baird downgrade comes after a mixed run for the stock, with a 1-day share price return of 1.08% and a 30-day share price return of 1.30%, set against a 1-year total shareholder return decline of 16.11%. Taken together, this...
SEHK:2007
SEHK:2007Real Estate

Country Garden Holdings (SEHK:2007) Valuation Check After December 2025 Sales Update

December sales update and why it matters for shareholders Country Garden Holdings (SEHK:2007) has released preliminary unaudited sales figures for December 2025, reporting contracted sales attributable to shareholders of about RMB 2.69b and contracted sales gross floor area of roughly 0.31 million square meters. For investors tracking this China focused developer, these monthly numbers provide another reference point alongside the company’s recent share price performance, multi year total...
ADX:ESG
ADX:ESGIndustrials

Undiscovered Gems in Middle East Stocks for January 2026

As Middle Eastern stock markets experience gains fueled by rising oil prices, investors are closely watching the impact of geopolitical tensions and shifts in U.S. economic policy on regional indices. In this dynamic environment, identifying promising stocks involves assessing companies that can leverage these macroeconomic trends while demonstrating resilience and growth potential.
ASX:TTT
ASX:TTTChemicals

How Titomic’s (ASX:TTT) European Leadership Refresh Could Shape Its Global Execution Story

Titomic Limited has announced leadership changes within its European division, with Chris Myers becoming President of Titomic Europe in early 2026 and Ferdy Touwen promoted to Deputy President & Head of European Operations, while outgoing leader Klaas Rozema moves into a Senior Executive Advisor role ahead of a planned sabbatical. This reshaping of Titomic’s European leadership concentrates commercial and operational responsibility in a refreshed team, aiming to support execution, customer...
NasdaqGM:ARCT
NasdaqGM:ARCTBiotechs

Does Arcturus Therapeutics (ARCT) JPM Conference Spotlight Clarify Its Long-Term Platform Credibility?

Arcturus Therapeutics Holdings Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at the Westin St. Francis Hotel in San Francisco, with Founder, President, CEO and Director Joseph E. Payne speaking. This high-profile conference appearance offered Arcturus a platform to showcase its pipeline and corporate story to a concentrated audience of healthcare-focused investors and industry peers. With this conference spotlight and recent share price...
TSE:4568
TSE:4568Pharmaceuticals

Is It Time To Reconsider Daiichi Sankyo Company (TSE:4568) After Recent Share Price Weakness?

If you are wondering whether Daiichi Sankyo Company’s current share price reflects its true worth, you are not alone. This article is designed to help you make sense of that question. The stock last closed at ¥3,540, with returns of 2.6% over 7 days, 5.3% over 30 days, a modest 0.3% year to date, and a 13.1% decline over 1 year. The 3 year and 5 year returns sit at 9.7% and roughly 0% respectively. Recent coverage of Daiichi Sankyo has focused on its position in the pharmaceuticals and...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

How Investors May Respond To Masimo (MASI) Record Hospital Contracts And Preliminary 2025 Revenue Growth

Masimo Corporation has already presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and released preliminary fourth-quarter and full-year 2025 results indicating approximately 12% quarterly and 9% annual revenue growth. Management also highlighted a record level of incremental contract value from new and expanded hospital agreements, underscoring the importance of long-term customer relationships to the business. We’ll now examine how the record incremental...
OTCPK:HONT
OTCPK:HONTBanks

Honat Bancorp (OTCPK:HONT) Earnings Growth Outpaces Long Run Trend And Fuels Margin Expansion Narrative

Honat Bancorp (HONT) has put another solid quarter on the board, with Q2 2025 revenue of US$11.4 million and basic EPS of US$2.57 feeding into trailing twelve month EPS of US$10.46 on revenue of US$44.6 million and net income of US$15.0 million. Over the past year, the company has seen revenue move from US$38.8 million to US$44.6 million on a trailing basis, while EPS climbed from US$8.33 to US$10.46, and earnings growth of 19% has supported a net profit margin of 33.5% compared with 31.2% a...
NYSE:FIS
NYSE:FISDiversified Financial

Is Fidelity National Information Services (FIS) Price Weakness Creating A Long Term Opportunity?

If you are wondering whether Fidelity National Information Services is priced attractively right now, you are not alone. Many investors are asking if the current share price lines up with the company’s underlying value. The stock recently closed at US$64.23, with returns of a 4.2% decline over 7 days, a 4.3% decline over 30 days, a 2.1% decline year to date, a 16.2% decline over 1 year, and a 44.0% decline over 5 years, which may influence how you think about its potential and its...
NasdaqGS:IMVT
NasdaqGS:IMVTBiotechs

Assessing Immunovant (IMVT) Valuation As Share Momentum Meets High Price To Book Multiple

Immunovant (IMVT) has been drawing attention after recent share moves that contrast a loss-making profile with fast annual growth in revenue and net income metrics, raising questions about how investors are weighing its clinical-stage risks. See our latest analysis for Immunovant. At a share price of $26.18, Immunovant’s recent 1 day share price return of 1.43% and 90 day share price return of 46.01% sit alongside a 1 year total shareholder return of 14.42% and 3 year total shareholder return...
SWX:SIKA
SWX:SIKAChemicals

Is It Time To Reassess Sika (SWX:SIKA) After A 30% One Year Share Price Slide?

If you have been wondering whether Sika shares are now offering value or still look expensive, this breakdown will help you put the current price into context before you commit fresh capital. Sika shares last closed at CHF149.10, with returns of an 8.7% decline over 7 days, a 6.7% decline over 30 days, an 8.9% decline year to date, and a 30.8% decline over 1 year, adding to a 39.6% decline over 3 years and a 35.0% decline over 5 years. Recent coverage around Sika has focused on its position...
LSE:BAKK
LSE:BAKKFood

January 2026's UK Penny Stocks To Watch

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping due to weak trade data from China, highlighting global economic uncertainties. Despite these broader market pressures, there remain opportunities for investors willing to explore beyond the mainstream indices. Penny stocks, often representing smaller or newer companies, can still offer potential growth when they are underpinned by strong financials and sound fundamentals.
NYSE:SJM
NYSE:SJMFood

Is J. M. Smucker (SJM) Pricing Reflect Its Long Term Cash Flow Potential

If you are wondering whether J. M. Smucker's current share price fairly reflects its long term value, you are not alone. This article is built to unpack exactly that question. The stock last closed at US$101.61, with returns of 5.9% over the past 7 days, 5.2% year to date and 3.8% over the last year. The 3 year return sits at a 27.3% decline and the 5 year return at 3.7%. Recent coverage around J. M. Smucker has focused on its position in packaged foods and consumer staples, as investors...